Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Retinoids or their analogs could treat skin pigmentation disorders like melasma and vitiligo.

Licorice component glycyrrhizic acid may reduce skin side effects from cancer treatment.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Older patients sticking to their prostate medication saw lasting health benefits.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

The herbal hair cream could help treat male pattern baldness by blocking a baldness-related enzyme and might be worth further investigation.

Thai rice bran extracts, especially from Tubtim Chumphae rice, can significantly reduce the activity of hair loss genes, with x-tocopherol showing potential as an anti-hair loss product.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

QLT0267 stops hair follicle cell growth and movement.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

4-O-Methylhonokiol helps protect skin cells from growth-stopping effects of a protein by regulating growth-related pathways.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.